Target Name: ZNF678
NCBI ID: G339500
Review Report on ZNF678 Target / Biomarker Content of Review Report on ZNF678 Target / Biomarker
ZNF678
Other Name(s): FLJ22822 | Zinc finger protein 678 isoform 1 | ZN678_HUMAN | ZNF678 variant 1 | OTTHUMP00000035838 | Zinc finger protein 678 | hypothetical protein MGC42493 | Zinc finger protein 678, transcript variant 1 | FLJ18355 | MGC42493 | zinc finger protein 678 | MGC15634

ZNF678: A Potential Drug Target Or Biomarker

ZNF678 (FLJ22822) is a protein that is expressed in various tissues of the human body, including the brain, heart, and gastrointestinal tract. It is a member of the ZNF family of proteins, which are known for their role in regulating gene expression and cell signaling. ZNF678 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, ZNF678 has generated a lot of interest as a potential drug target or biomarker.

One of the key features of ZNF678 is its ability to interact with various signaling pathways. It has been shown to play a role in several signaling pathways, including the TGF-β pathway, the NF-kappa-B pathway, and the PI3K/AKT pathway. The TGF-β pathway is involved in cell growth, differentiation, and survival, and is a well-established pathway for the development of many diseases, including cancer. The NF-kappa-B pathway is involved in inflammation and stress responses, and is implicated in a wide range of diseases, including neurodegenerative disorders. The PI3K/AKT pathway is involved in the regulation of cell survival and metabolism, and is implicated in many diseases, including cancer.

In addition to its role in these signaling pathways, ZNF678 has also been shown to interact with specific proteins that are involved in disease progression. For example, ZNF678 has been shown to interact with the protein SMAD4, which is involved in the regulation of gene expression and is often mutated in many diseases, including cancer. Similarly, ZNF678 has been shown to interact with the protein NF-kappa-B2, which is involved in inflammation and stress responses and is implicated in many diseases, including neurodegenerative disorders.

These interactions between ZNF678 and other proteins make it a potential drug target or biomarker. By targeting these interactions, researchers could potentially develop drugs that inhibit the activity of ZNF678 and its downstream targets, leading to a wide range of potential therapeutic benefits. For example, by inhibiting the activity of ZNF678 and its downstream targets, researchers could potentially develop drugs that are effective in treating a wide range of diseases, including cancer, neurodegenerative disorders, and autoimmune disorders.

Another potential application of ZNF678 as a drug target or biomarker is its role in the regulation of stem cell behavior. Stem cells are a highly promising technology that have the potential to be used to treat a wide range of diseases, including cancer, neurodegenerative disorders, and autoimmune disorders. However, the regulation of stem cell behavior is a complex process, and the precise mechanisms that control this regulation are not well understood. ZNF678 has been shown to play a role in the regulation of stem cell behavior, and researchers are interested in studying its potential as a drug target or biomarker in this context.

In conclusion, ZNF678 is a protein that has been shown to play a role in several signaling pathways and has been implicated in the development and progression of many diseases. As a result, ZNF678 has generated a lot of interest as a potential drug target or biomarker. Its interactions with other proteins and its role in the regulation of stem cell behavior make it a promising target for future research and development. Further studies are needed to fully understand the potential of ZNF678 as a drug target or biomarker, and to develop safe and effective treatments for a wide range of diseases.

Protein Name: Zinc Finger Protein 678

Functions: May be involved in transcriptional regulation

The "ZNF678 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF678 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8